Peptide record

TPDB19729

HFIAP-1 (1-18)[H12K,G14F] Antibacterial Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB19729
HFIAP-1 (1-18)[H12K,G14F]
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia DBAASP
standard
No
A 18-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia and DBAASP, with an available 3D structural model.
Sequence
GFFKKAWRKVKKAFRRVL
Physicochemical Analysis
C110H177N33O19
NDCEQHIMPSTY
K
2265.83
12.72
8
0
9
+8
1.39
-0.561
65.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
242.74
0
Residue Composition
number
2
A
3
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
1
L
5
K
0
M
3
F
0
P
0
S
0
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 1 K: 5 M: 0 F: 3 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 2
Chemical Descriptors
18
C110H177N33O19
2265.83
12.72
+8
1.39
-0.561
Evidence Records 5 records
Evidence 1 Activity

Activity

<10% Hemolysis
Toxicity
512 µg/mL
Hemolytic Cytotoxic
<10% Hemolysis | 512 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo. | Biochem Pharmacol | 2020
Evidence 2 Activity

Activity

42% Killing
Toxicity
200 µg/mL
Cytotoxic
42% Killing | 200 | µg/mL | target cell: Mouse splenocytes

Target

Mouse splenocytes

Source & Reference

NA
DBAASP
An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo. | Biochem Pharmacol | 2020
Evidence 3 Activity

Activity

20% Killing
Toxicity
128 µg/mL
Cytotoxic
20% Killing | 128 | µg/mL | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo. | Biochem Pharmacol | 2020
Evidence 4 Activity

Activity

40% Killing
Toxicity
128 µg/mL
Cytotoxic
40% Killing | 128 | µg/mL | target cell: Human gastric epithelial cells GES-1

Target

Human gastric epithelial cells GES-1

Source & Reference

NA
DBAASP
An active domain HF-18 derived from hagfish intestinal peptide effectively inhibited drug-resistant bacteria in vitro/vivo. | Biochem Pharmacol | 2020
Evidence 5 Activity

Target

Cutibacterium acnes

Source & Reference

DBAASP